510(k) K023592

SERAQUEST ANTI-THYROGLOBULIN by Quest Intl., Inc. — Product Code DDC

K023592 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "SERAQUEST ANTI-THYROGLOBULIN". The FDA issued a decision of Substantially Equivalent on January 6, 2003. The device falls under product code DDC (Thyroglobulin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5870. Quest Intl., Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 6, 2003
Date Received
October 25, 2002
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Thyroglobulin, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5870
Review Panel
IM
Submission Type